|
|
cell adhesion
|
GO:0007155 |
329 |
0.302
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.268
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.249
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.244
|
|
|
|
positive regulation of hair follicle development
|
GO:0051798 |
6 |
0.243
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.237
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.225
|
|
|
|
ventricular cardiac muscle cell action potential
|
GO:0086005 |
4 |
0.219
|
|
|
|
foramen ovale closure
|
GO:0035922 |
1 |
0.171
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.169
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
33 |
0.140
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.125
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.125
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.119
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.115
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.115
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.112
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.112
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.112
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.109
|
|
|
|
intermediate filament organization
|
GO:0045109 |
15 |
0.109
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.109
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.107
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.107
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.107
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.106
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.104
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.102
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.100
|
|
|
|
intermediate filament cytoskeleton organization
|
GO:0045104 |
26 |
0.099
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.098
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.097
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.096
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.096
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.095
|
|
|
|
intermediate filament based process
|
GO:0045103 |
27 |
0.093
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.092
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.092
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.089
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.088
|
|
|
|
regulation of membrane depolarization during action potential
|
GO:0098902 |
1 |
0.087
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.087
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.086
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.086
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.084
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.083
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.081
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.080
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.080
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.080
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.080
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.080
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.080
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.079
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.079
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.079
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.078
|
|
|
|
cell communication by electrical coupling involved in cardiac conduction
|
GO:0086064 |
2 |
0.078
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.077
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.076
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.076
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.076
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.075
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.075
|
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.074
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.073
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.071
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.069
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.069
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.068
|
|
|
|
regulation of keratinocyte differentiation
|
GO:0045616 |
11 |
0.068
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.068
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.065
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.064
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.062
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.062
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.061
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.061
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.061
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.060
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.060
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.060
|
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.059
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.059
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.059
|
|
|
|
hepatocyte apoptotic process
|
GO:0097284 |
11 |
0.059
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.058
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.058
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.057
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.057
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.056
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.056
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.055
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.055
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.054
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.054
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.054
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.053
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.053
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.053
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.053
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.052
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.051
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.051
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.051
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.051
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.050
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.050
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.050
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.050
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.050
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.049
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.049
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.049
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.049
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.048
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.048
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.047
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.047
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.046
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.046
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.046
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.045
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.045
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.045
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.044
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.044
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.044
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.043
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.043
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.043
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.043
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.043
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.042
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.042
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.042
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.042
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.042
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.042
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.042
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.042
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.042
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.041
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
23 |
0.041
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.041
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.041
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.041
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.041
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.041
|
|
|
|
sa node cell to atrial cardiac muscle cell signalling
|
GO:0086018 |
4 |
0.041
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.041
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.040
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.040
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.040
|
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.040
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.040
|
|
|
|
cerebellum formation
|
GO:0021588 |
1 |
0.040
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.040
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.040
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.039
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.039
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.039
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.039
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.038
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.038
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.038
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.038
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.038
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.037
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.037
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
21 |
0.037
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.037
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.037
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.037
|
|
|
|
ventricular compact myocardium morphogenesis
|
GO:0003223 |
2 |
0.037
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.037
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.036
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.036
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.036
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.036
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.036
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.036
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.036
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.035
|
|
|
|
corticotropin hormone secreting cell differentiation
|
GO:0060128 |
3 |
0.035
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.035
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.035
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.035
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.035
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.035
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.035
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.035
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.035
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.035
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.034
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.034
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.034
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.034
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.034
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.033
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.033
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.033
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.033
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.033
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.033
|
|
|
|
regulation of membrane depolarization during cardiac muscle cell action potential
|
GO:1900825 |
1 |
0.033
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.033
|
|
|
|
spemann organizer formation
|
GO:0060061 |
2 |
0.032
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.032
|
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.032
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.032
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.032
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.032
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.031
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.031
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.031
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.031
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
translation
|
GO:0006412 |
93 |
0.031
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.031
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.031
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.030
|
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.030
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.030
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.030
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.030
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.030
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.030
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.030
|
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.030
|
|
|
|
positive regulation of epidermis development
|
GO:0045684 |
13 |
0.030
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.030
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.030
|
|
|
|
transforming growth factor beta secretion
|
GO:0038044 |
1 |
0.029
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.029
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.029
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.029
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.029
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.029
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.029
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.029
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.029
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.029
|
|
|
|
cardiac muscle cell contraction
|
GO:0086003 |
7 |
0.029
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.029
|
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
49 |
0.028
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.028
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.028
|
|
|
|
positive regulation of cell cell adhesion mediated by cadherin
|
GO:2000049 |
2 |
0.028
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.028
|
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.028
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.028
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.028
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.028
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.028
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.027
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.027
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.027
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.027
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.027
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.027
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.027
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.027
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.027
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.027
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.027
|
|
|
|
regulation of white fat cell proliferation
|
GO:0070350 |
2 |
0.027
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.027
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.027
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.027
|
|
|
|
regulation of hair cycle
|
GO:0042634 |
11 |
0.027
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.026
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.026
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.026
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.026
|
|
|
|
regulation of endodermal cell differentiation
|
GO:1903224 |
2 |
0.026
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.026
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.026
|
|
|
|
positive regulation of branching involved in lung morphogenesis
|
GO:0061047 |
4 |
0.026
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.026
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.026
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.026
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.026
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.026
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.026
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.026
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.025
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.025
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.025
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.025
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.025
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.025
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.025
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.025
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.025
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.025
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.025
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.024
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.024
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.024
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.024
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.024
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.024
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.024
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.024
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.024
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.024
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.024
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.024
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.024
|
|
|
|
response to parathyroid hormone
|
GO:0071107 |
3 |
0.024
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.024
|
|
|
|
chondrocyte morphogenesis
|
GO:0090171 |
1 |
0.024
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.024
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.024
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.024
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.023
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.023
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.023
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.023
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.023
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.023
|
|
|
|
positive regulation of jnk cascade
|
GO:0046330 |
46 |
0.023
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.023
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.023
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.023
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.023
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.023
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.023
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.023
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.023
|
|
|
|
establishment of skin barrier
|
GO:0061436 |
14 |
0.022
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.022
|
|
|
|
branching involved in mammary gland duct morphogenesis
|
GO:0060444 |
27 |
0.022
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.022
|
|
|
|
negative regulation of alcohol biosynthetic process
|
GO:1902931 |
4 |
0.022
|
|
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.022
|
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.022
|
|
|
|
neurohypophysis development
|
GO:0021985 |
2 |
0.022
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
13 |
0.022
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.022
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.022
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.022
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.022
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.022
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.022
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.022
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.022
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.022
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.022
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.022
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.022
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.022
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.021
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.021
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.021
|
|
|
|
loop of henle development
|
GO:0072070 |
10 |
0.021
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.021
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.021
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.021
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
16 |
0.021
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.021
|
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.021
|
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.021
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.021
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.021
|
|
|
|
regulation of interleukin 10 secretion
|
GO:2001179 |
4 |
0.021
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.021
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.021
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.021
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.020
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.020
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.020
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.020
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.020
|
|
|
|
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis
|
GO:0060598 |
2 |
0.020
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.020
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.020
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.020
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.020
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.020
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.020
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.020
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.020
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.020
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.020
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.020
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.020
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.020
|
|
|
|
regulation of epidermal cell differentiation
|
GO:0045604 |
21 |
0.020
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.020
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.020
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.020
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.019
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.019
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.019
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.019
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.019
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.019
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.019
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.019
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.019
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.019
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.019
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.019
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.019
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.019
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.019
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.019
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.019
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.019
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.019
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.019
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.019
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.019
|
|
|
|
establishment or maintenance of neuroblast polarity
|
GO:0045196 |
1 |
0.019
|
|
|
|
positive regulation of translation
|
GO:0045727 |
19 |
0.019
|
|
|
|
interleukin 8 secretion
|
GO:0072606 |
3 |
0.019
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.019
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.018
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.018
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.018
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.018
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.018
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.018
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.018
|
|
|
|
olfactory lobe development
|
GO:0021988 |
32 |
0.018
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.018
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.018
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.018
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.018
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.018
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.018
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.018
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.018
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.018
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.018
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.018
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
61 |
0.018
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.018
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.018
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
28 |
0.018
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.018
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.018
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.018
|
|
|
|
epithalamus development
|
GO:0021538 |
2 |
0.018
|
|
|
|
cell migration involved in mesendoderm migration
|
GO:0090134 |
1 |
0.018
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.018
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.018
|
|
|
|
regulation of cardiac muscle cell action potential
|
GO:0098901 |
1 |
0.018
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.017
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.017
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.017
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.017
|
|
